Experiment: 5TGY

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCACB	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
2	3D CBCA(CO)NH	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
3	3D HNCO	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
4	3D CO(CA)NH	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
5	3D CCH-TOCSY	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
6	3D simultaneous NOESY	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
7	2D 1H-13C HSQC aliphatic	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900
8	2D 1H-15N HSQC	780 uM [U-100% 13C; U-100% 15N] holo-PS1	95% H2O/5% D2O	100 mM NaCl, 50 mM NaPi mM	7.5	1 atm	298	Bruker AVANCE II 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	900

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	AutoAssign		Zimmerman, Moseley, Kulikowski and Montelione
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	peak picking	XEASY		Bartels et al.
4	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
5	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
6	data analysis	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.